TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
PTCT

PTC Therapeutics Inc

Healthcare · Biotechnology

62.70$ +0.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

PTC Therapeutics Inc (PTCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,731 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PTCT
Line item 2004 2005 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.6 5.0 99 29 31 23 37 83 194 265 307 381 539 699 938 807 1,731
25 28 72 -5.2 55 80 122 118 4.6 13 12 19 32 45 65 57 72
– – 99 34 -24 -57 37 83 190 252 295 362 506 654 872 749 1,659
20 21 59 46 55 80 122 118 117 172 257 478 541 651 667 534 455
– – 16 15 25 45 82 97 121 154 203 245 285 300 349 301 347
– – 68 56 77 122 204 215 254 348 536 794 881 1,102 1,312 1,052 802
– – 31 -27 -45 -99 -167 -132 -64 -116 -241 -432 -374 -447 -440 -303 857
0.0 0.0 2.4 1.2 6.1 1.2 2.4 8.3 12 13 12 56 86 91 129 167 152
– – 29 -26 -52 -98 -170 -142 -78 -128 -240 -403 -518 -587 -696 -363 697
– – -2.3 1.2 6.2 -4.7 0.5 0.6 1.3 0.0 12 35 5.6 -28 -70 0.2 14
– – 31 -26 -52 -94 -170 -142 -79 -128 -252 -438 -524 -559 -627 -363 683
– – 33 -24 -43 -97 -164 -129 -47 -89 -195 -303 -368 -368 -330 -120 888

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?